YARDLEY, Pa., April 23, 2018 -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that CEO Peter Miller and President/COO Ramy Mahmoud, MD, MPH, have been named finalists for the EY Entrepreneur of the Year® 2018 Award in the Greater Philadelphia area. The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. The Optinose executives were selected as finalists by a panel of independent judges. Award winners will be announced at a special gala event on June 14, 2018, at the Kimmel Center for the Performing Arts.
“We are both honored to be named finalists for the EY Entrepreneur of the Year 2018 and to represent our terrific company and this great region,” said Peter Miller, CEO of Optinose. “We recognize that our accomplishments and success occur only through the efforts of our entire team of exceptional individuals who all are focused on a single mission to improve lives. One of our core values is friendship and we are fortunate of the great partnership we have together and the resulting trust and respect that we believe enable us collectively to achieve so much more than we could individually. We thank EY for this honor and their support of entrepreneurialism in Greater Philadelphia and throughout the world.”
About EY Entrepreneur of the Year
Entrepreneur of the Year, founded by EY, is a prestigious business awards program for entrepreneurs, chosen from an independent panel of judges including entrepreneurs and prominent leaders from business, finance, and the local community. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. Entrepreneur of the Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities and more than 60 countries.
The Entrepreneur of the Year Awards are nationally sponsored in the US by SAP America, Merrill Corporation and the Ewing Marion Kauffman Foundation. In Greater Philadelphia, sponsors also include PNC Bank, Pine Hill Group, Murray Devine & Company, SolomonEdwardsGroup, Ballard Spahr LLP, Morgan, Lewis & Bockius LLP, Pepper Hamilton LLP and Simkiss & Block.
About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
[email protected]
267.521.0531
Optinose Media Contact
Kate Traynor, Sloane & Company
[email protected]
212.446.1871


Bathla Group Hires Administrators as Australia Housing Slump Deepens
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
OpenAI AI Agent Swarm Behind Hugging Face Hack
Tesla Raises Cybertruck Prices by $5,000 in US
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Nvidia Options Price in $280 Billion Earnings Swing
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Google Expands Gemini Enterprise With AI Tools for Legal Sector
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Luxshare Shares Rise as First-Half Profit Jumps 18%
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 



